| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/04/2009 | US7569688 Propane-1, 3-dione derivative |
| 08/04/2009 | US7569570 N-{4-[1-(2,6-difluorobenzyl)-3-(4-fluorophenyl)-5-({methy[2-(2-oxo-1-piperidinyl)ethyl]amino}methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-N'-ethylurea; antagonistic action for gonadotropin-releasing hormone |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | CA2653189A1 Estrogenic compounds, process for their production and pharmaceutical uses thereof |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 07/30/2009 | WO2009040085A3 Use of exendin-4 and optionally salusin-alpha as therapeutic agent(s) |
| 07/30/2009 | WO2009013310A3 Process for preparing 7-alpha-[9-(4,4,5,5,5-pentafluorothiopentyl)nonyl]estra-1,3,5(10)-triene-3,17-beta-diol |
| 07/30/2009 | WO2009002427A3 Methods of synthesizing cinacalcet and salts thereof |
| 07/30/2009 | US20090192145 Spiro-Imidazo Compounds |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191194 Inhibition of protein kinase c alpha for the treatment of cardiovascular diseases |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/29/2009 | EP2083011A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/29/2009 | EP2081958A1 Peptide extended insulins |
| 07/29/2009 | EP2081951A1 Progesterone receptor antagonists |
| 07/29/2009 | EP2081910A1 Novel compounds |
| 07/29/2009 | EP1638968B1 Hexahydropyridoisoqinolines as dpp-iv inhibitors |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518735C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/23/2009 | WO2009066008A4 Novel beta-hydroxyketones and beta-alkoxyketones with estrogenic activity |
| 07/23/2009 | WO2009012734A3 New salts of bazedoxifene |
| 07/23/2009 | US20090186014 Method for treatment of pancreatitis |
| 07/23/2009 | DE19521753B4 Monomere Insulinanalogonformulierungen Monomeric insulin analog formulations |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2079525A1 Calcium receptor modulating agents |
| 07/22/2009 | EP2079454A2 Sugar coatings and methods therefor |
| 07/22/2009 | EP1569628B1 Novel use of lycopene for the treatment of diseases associated with androgen signalling |
| 07/22/2009 | EP1492761B1 Amino acids with affinity for the alpha-2-delta-protein |
| 07/22/2009 | EP1392337B2 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | CA2474698C Polymer-based compositions for sustained release |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/16/2009 | WO2009089093A1 Thyroid hormone receptor agonists |
| 07/16/2009 | WO2008099185A8 Human monoclonal antibodies to the thyrotropin receptor which act as antagonists |
| 07/16/2009 | WO2008058074A3 Sugar coatings and methods therefor |
| 07/16/2009 | WO2005011680A8 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 07/16/2009 | US20090182057 Deuterated aminoglycidal compounds |
| 07/16/2009 | US20090182047 Utilization of dialkylfumarates |
| 07/16/2009 | US20090181085 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 07/15/2009 | EP1831240B1 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same |
| 07/15/2009 | EP1268802B1 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 07/15/2009 | EP1141015B1 Insulin-like growth factor (igf) i mutant variants |
| 07/15/2009 | EP1075272B1 Methods for treating diabetes by inhibiting gdf-8 |
| 07/15/2009 | CN101481405A Somatostatin-dopamine chimeric analogs |
| 07/15/2009 | CN101481359A Cyclic protein tyrosine kinase inhibitors |
| 07/15/2009 | CN100513570C Regulation effect of conjugated frame transport protein ABC1 |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100513406C Novel quinuclidine derivatives and their use |
| 07/14/2009 | US7560454 1-(4-(10,11-dihydro-5H-pyrrolo[2,1-c](1,4)benzodiazepine-10-ylcarbonyl)-2-methyl-benzylcarbamoyl)-4methoxy-L-proline-N,N-dimethylamide; vasopressin agonists particularly useful in the treatment of urogenital disorders central diabetes insipidus, nocturnal enuresis and nocturia; blood disorders |
| 07/14/2009 | CA2366754C Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 07/14/2009 | CA2331410C Methods for treating diabetes by inhibiting gdf-8 |
| 07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
| 07/09/2009 | WO2009085880A2 C-21 thioethers as glucocorticoid receptor agonists |
| 07/09/2009 | WO2009085879A2 C20-c21 substituted glucocorticoid receptor agonists |
| 07/09/2009 | WO2009085584A1 6h-dibenz0 [b, e] oxepine derived nonsteroidal mineralocorticoid receptor antagonists |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009083272A2 19-NOR-STEROID DERIVATIVES WITH A 15α,16α-METHYLENE GROUP AND A SATURATED 17,17-SPIROLACTONE RING, USE THEREOF, AND MEDICAMENTS CONTAINING SAID DERIVATIVES |
| 07/09/2009 | WO2009083271A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083270A1 15,16-methylene-steroid-17,17-lactol derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083269A1 15,16-METHYLENE-17-HYDROXY-19-NOR-21-CARBOXYLIC ACID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING SAID DERIVATIVE |
| 07/09/2009 | WO2009083268A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083267A2 Steroid-17,17-lactol derivative, use thereof, and medicament containing said derivative |
| 07/09/2009 | WO2009083266A1 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE |
| 07/09/2009 | WO2009082881A1 Tetrahydro-imidazo[1,5-a]pyrazine derivatives, preparation methods and medical uses thereof |
| 07/09/2009 | US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism |
| 07/09/2009 | US20090176764 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 07/09/2009 | CA2710934A1 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof and medicinal products containing the derivative |
| 07/09/2009 | CA2710495A1 19-nor-steroid derivatives with a 15.alpha., 16.alpha.-methylene group and a saturated 17,17-spirolactone ring, use thereof and medicinal products containing these derivatives |
| 07/09/2009 | CA2710491A1 17-hydroxy-19-nor-21-carboxylic acid-steroid .gamma.-lactone derivative, use thereof and medicinal products containing the derivative |
| 07/09/2009 | CA2710486A1 15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative, use thereof and drug containing the derivative |
| 07/09/2009 | CA2710240A1 C-21 thioethers as glucocorticoid receptor agonists |
| 07/09/2009 | CA2710149A1 C20-c21 substituted glucocorticoid receptor agonists |
| 07/09/2009 | CA2708394A1 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid-steroid .gamma.-lactone derivative, use thereof and medicinal products containing the derivative |
| 07/09/2009 | CA2706735A1 Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives, preparation process and medicinal use thereof |
| 07/08/2009 | EP2077262A1 Iminopyridine derivative and use thereof |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | CN100509794C Therapeutic heterocyclic compounds |
| 07/08/2009 | CN100509774C Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | CA2406790C Sustained release formulations |
| 07/02/2009 | WO2009082437A2 Selective androgen receptor modulators (sarms) and uses thereof |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009080223A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |